Skip to Content

Vaccines, Volume 1, Issue 1

2013 March - 4 articles

  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
  • You may sign up for email alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.

Articles (4)

  • Concept Paper
  • Open Access
1 Citations
7,371 Views
19 Pages

25 January 2013

Part I. Basic Principles. TB vaccines cannot prevent establishment of the infection. They can only prevent an early pulmonary tubercle from developing into clinical disease. A more effective new vaccine should optimize both cell-mediated immunity (CM...

  • Article
  • Open Access
6 Citations
10,262 Views
24 Pages

A Modified Bacillus Calmette-Guérin (BCG) Vaccine with Reduced Activity of Antioxidants and Glutamine Synthetase Exhibits Enhanced Protection of Mice despite Diminished in Vivo Persistence

  • Carolyn M. Shoen,
  • Michelle S. DeStefano,
  • Cynthia C. Hager,
  • Kyi-Toe Tham,
  • Miriam Braunstein,
  • Alexandria D. Allen,
  • Hiriam O. Gates,
  • Michael H. Cynamon and
  • Douglas S. Kernodle

11 January 2013

Early attempts to improve BCG have focused on increasing the expression of prominent antigens and adding recombinant toxins or cytokines to influence antigen presentation. One such modified BCG vaccine candidate has been withdrawn from human clinical...

  • Article
  • Open Access
5 Citations
8,938 Views
17 Pages

Factors Affecting the Acceptance of Pandemic Influenza A H1N1 Vaccine amongst Essential Service Providers: A Cross Sectional Study

  • Alice Beattie,
  • Katie Palmer,
  • Emily Rees,
  • Zoe Riddell,
  • Charlotte Roberts and
  • Rachel Jordan

20 December 2012

Although mentioned in the UK pandemic plan, essential service providers were not among the priority groups. They may be important targets of future influenza pandemic vaccination campaigns. Therefore, we conducted a cross-sectional survey among 380 e...

  • Review
  • Open Access
24 Citations
16,207 Views
16 Pages

Peptide Vaccine Therapy in Colorectal Cancer

  • Aleksandra Bartnik,
  • Ajit Johnson Nirmal and
  • Shi-Yu Yang

24 August 2012

Colorectal cancer is the third most common cause of cancer-related deaths and the second most prevalent (after breast cancer) in the western world. High metastatic relapse rates and severe side effects associated with the adjuvant treatment have urge...

XFacebookLinkedIn
Vaccines - ISSN 2076-393X